Clinical trial · Interventional
DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer
Development And Evaluation of The Effectiveness of A Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study was designed to develop and evaluate the effectiveness of a web-based supportive care program for individuals diagnosed with colorectal cancer undergoing cancer treatment. The program's effectiveness is evaluated based on the symptom burden and quality of life experienced by patients during cancer treatment. This randomized controlled trial was conducted with the participation of patients diagnosed with colorectal cancer receiving treatment at the Outpatient Chemotherapy Unit of Koç University Hospital. Participants were divided into two groups: an intervention group and a control group. Patients in the intervention group were provided with access to the web-based 'Sağlıkta Buluşalım (Meet in Health) Supportive Care Program' for 3 months in addition to routine care, while the control group received standard care. Data collection tools included a Descriptive Information Form, Edmonton Symptom Assessment System (ESAS), Functional Assessment of Cancer Therapy-Colorectal (FACT-C), Website Usability Scale, and a Telephone Follow-up Form. Statistical analyses, including Mann-Whitney U, Pearson Chi-Square, Fisher's Exact, and Friedman tests, were planned to compare symptom levels and quality of life scores within and between groups over time.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
| Colorectal (Colon or Rectal) Cancer | Childhood Colorectal Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| web based supportive care programme | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- control group
- description
- Patients in the control group received standard treatment and care at the hospital where they were followed up. Initial interviews with patients were conducted in person. After obtaining verbal and written consent from patients who volunteered to participate in the study, the "Edmonton Symptom Assessment Scale" and the "Functional Assessment in Cancer Treatment-Colorectal Cancer Scale" were administered. The same scales were administered again via telephone one month (second follow-up) and three months (final follow-up) after the initial data collection. Institutional Standard Care: At the institution where the study was conducted, patients receiving chemotherapy were informed by their primary nurse about the medication protocol, drug-related side effects, and possible symptoms. They were also given educational brochures on topics such as pain, nausea, and precautions to take when using port needles. Nurses in the outpatient chemotherapy unit additionally planned the patients' treatm
- type
- EXPERIMENTAL
- label
- intervention group
- description
- Experimental Group Patients in the experimental group used the web-based "Meet in Health Support Care Program" for 3 months in addition to routine care. The initial interview with the patients was conducted face-to-face. Verbal and written consent was obtained from patients who volunteered to participate in the study. During the interview, the goal and content of the study were explained, the website was introduced, and information on its use was provided. In addition, the Edmonton Symptom Assessment Scale and the Functional Assessment in Cancer Treatment-Colorectal Cancer Scale were administered during the first interview. One month (second follow-up) and three months (final follow-up) after the collection of the initial data, the same scales were administered again by telephone interviews with the patients. In the final follow-up (3rd month), the "Website Usability Scale" was administered to the patients to evaluate their satisfaction with the support care program.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of colon cancer and receiving cancer treatment (within the first 3 months of diagnosis) * Being 18 years of age or older * Being able to read, understand, and communicate in Turkish * Having internet access * Being able to use a smartphone or computer * Having access to a smartphone or computer * Voluntary participation in the study Exclusion Criteria: * Having a psychiatric illness * Having a disability that impairs cognitive functions * Refusing to participate in the study * Poor general health * Incompatibility between treatment appointments and the study's data collection schedule
References
Publications (0)
Data not yet available